$HNR1 (-0.75%)

I recently invested in Hannover Rück SE because I consider the current share price level to be attractive in relation to the operating performance and dividend policy.

Hannover Re is one of the world's largest reinsurers and has been benefiting from a generally improved market environment for some time. Price discipline in the reinsurance market is high, while at the same time demand for reinsurance cover continues to rise. This is having a positive effect on margins and earnings quality.

I am currently particularly impressed by the company's dividend strategy. Following a very strong financial year, a significantly higher dividend has been announced. The combination of basic and special dividends leads to an attractive dividend yield without compromising the Group's capital strength. At the same time, Hannover Re pursues a clearly communicated dividend policy that is geared towards reliability and sustainability.

The company also has a solid balance sheet. The return on equity is well above the company's own targets, and the capitalization provides a sufficient buffer to absorb major losses or volatile years - an important point in the reinsurance industry.

All in all, I currently see Hannover Re as a solid, defensive portfolio component that can impress with both current income and long-term value stability. The entry is based on a long-term investment horizon and a focus on dividend continuity.

I would be interested to hear your current assessment of Hannover Re - especially in comparison with other reinsurers such as Munich Re or international competitors.

I started at €236 and think the price is very fair 😜

$ALV (+0.37%)
$HNR1 (-0.75%)
#versicherung
#dividende

Novo Nordisk 3.0% $NOVO B (-0.12%) NVO

LVMH 2.0% $LVMH

Pernod Ricard 6.35% $RI (-1.72%)

Imperial Brands 5.5% $IMB (+1.16%)

BAT 6.2% $BATS (+0%)

Sunrise Communications 8.00%

Nestle 4.05% $NESN (+0.04%)

Roche 2.85% $ROG (+0.65%)

Novartis 3.07% $NOVN (+0.11%)

Shell 4.07% $SHEL (+0.01%)

German Post 3.86% $DHL (-0.39%)

Swisscom 3.75% $SCMN (+1.22%)

German Telekom 3.52% $DTE (+0.24%)

Strabag 2.72% $STR (+0.99%)

Vonovia 4.82% $VNA (-0.66%)

BASF 5.01% $BAS (-1.57%)

Puma 2.8% $PUMA

Hannover Re 3.62% $HNR1 (-0.75%)

Munich Re 3.8% $MUV2 (+0.51%)

Allianz 4.00% $ALV (+0.37%)

BP 5.76% $BP. (-0.16%)

Spotify

https://open.spotify.com/episode/1zt05UZlehInr81iaZMdY5?si=e676f0a812014943

YouTube

https://youtu.be/BpCIIJYfxHA

Appple Podcast

https://podcasts.apple.com/de/podcast/125-20-europ%C3%A4ische-dividenden-aktien/id1695869891?i=1000744769342

🔹 Hannover Re $HNR1 (-0.75%)

Strong reinsurer with a robust business model, reliable cash flows and an attractive dividend policy. For me, a defensive building block for portfolio stability.

🔹 Omada Health $OMDA (-0.72%)

Exciting health tech company with a focus on digital prevention and chronic diseases. Benefits from the digitalization megatrend in the healthcare sector and offers long-term growth potential.

Good mix of stability & growth for the start of the new year 🚀

🟢 🚀

$GOOGL (+0.6%) +11%

$MC (+0.11%) +4%

$HNR1 (-0.75%) +3,4%

$BRK.B (-0.11%) +3,7%

$8001 (-0.09%) +2%

🔴🛝

$BTC (-0.36%) -15%

$MSFT (+0.8%) -6%

@Tenbagger2024 I have now done it like this

Following a very strong business performance, Hannover Re has raised its profit forecast for 2025 to around EUR 2.6 billion. In the first nine months of the year, net profit rose by 7.7 percent to EUR 2.0 billion, while the return on equity of 22 percent was well above the target figure.

Property and casualty reinsurance in particular developed profitably: the combined ratio improved to 86 percent and major losses remained well below budget at EUR 1.18 billion. Life and health reinsurance also posted stable results, while investments achieved a return of 2.8 percent despite targeted loss realizations.

For 2026 Hannover Re expects a further increase in Group net income to at least EUR 2.7 billion and a return on investment of around 3.5 percent.

At the same time, the dividend policy was adjusted: In future, around 55 percent of net profit is to be distributed, with the aim of a stable or rising dividend. Overall, the reinsurer confirms its strong market position and is ideally positioned for further profitable growth.

$HNR1 (-0.75%)

In recent weeks, I have been able to lower my entry prices for individual stocks here and there ( $HNR1 (-0.75%)
$CNR (-0.26%)
$NOVO B (-0.12%)
$DTE (+0.24%)
$VICI (-0.37%)
$ADP (+0.22%) ), but I still think the market as a whole is currently somewhat overvalued. I will therefore be using less of the variable portion of my savings rate to buy individual shares over the next few quarters.

The central banks are a little more reluctant to cut interest rates, so hopefully there will be good opportunities to buy bonds for a few more months, which I would like to finance with the cuts in the savings rate for individual shares.

This month I have already added to my French bonds and will continue to do so, as they are currently trading at historically low levels. Although interest rates are falling, the risk premium for French government bonds is rising due to the budget deficits, which naturally causes the price to fall. However, as I do not believe that the solvency of the state is seriously at risk, I am taking advantage of the low quotation to achieve a price return in addition to the coupon. During the negative interest rate phase, the bond quoted at over 230% at times.

I have decided to add the German reinsurers to my portfolio. Do you prefer $HNR1 (-0.75%) (or Talanx $TLX (+0.19%) ) or $MUV2 (+0.51%) ?

Hannover Re $HNR1 (-0.75%) is well above its medium-term targets for 2024-2026. The company had set itself a return on equity of over 14% - it already reached 21.2% in 2024 and even 23% in the first half of 2025. The EBIT target of more than 5% growth was also far exceeded.

Hannover Re intends to continue this strong development until 2026 and at the same time ensure stability: At over 260%, the solvency ratio remains well above the target of 200%, while the CSM result (underwriting margin) continues to grow. In addition, the dividend is to continue to rise annually in the future; there is no information yet on the amount of the dividend.

$HNR1 (-0.75%) Hannover Re is increasing the payout ratio for the regular dividend from 46% to 55% of Group net income and integrating the previous special dividend into the regular dividend. This change will take effect for the first time for the 2025 financial year.

I added 4 shares of Hannover Re to my portfolio today and will continue to build on this position.

Hannover Re is one of the largest reinsurers in the world and is considered a solid dividend stock.

🔎 Facts about Hannover Re:

• 🌍 3rd largest reinsurer worldwide
• 💰 Market capitalization: approx. € 29 billion
• 📊 Dividend yield: currently around 3.67%
• 🏦 Payout ratio: approx. 45% of the profit
• 📈 Profit 2024: over € 2.4 billion - a record figure
• 📉 P/E ratio currently around 13 (fair valuation compared to the sector)

💡 Why the buy?

• Stable business model despite fluctuating natural catastrophe losses
• Very shareholder-friendly dividend policy (basic + possible special dividend)
• Good long-term growth potential due to increasing demand for reinsurance

👉 What do you think of reinsurers in your portfolio - boring but stable dividend payers or underestimated growth stocks?